Skip to main content
Premium Trial:

Request an Annual Quote

Rarecell's CTC/CTM Technology Chosen for Study into Prostate Cancer

NEW YORK (GenomeWeb News) – French biotechnology firm Rarecells today announced that Ipsen and Institut Gustave Roussy, has selected its ISET technology for a study into patients with prostate cancer.

The technology is for circulating tumor cell and circulating tumor microemboli isolation.

The goal of the study is to use ISET, which stands for Isolation by Size of Epithelial/Throphoblastic Tumor cells, for the molecular analysis and genetic characterization of circulating cancer cells, Rarecells said.

"CTCs captured as a liquid biopsy from blood are expected to provide increasingly important clinical information on therapy choice, effectiveness, and drug resistance," Françoise Farace, head of the Circulating Cells Laboratory at Institut Gustave Roussy, said in a statement. "ISET is a powerful tool for capturing high levels of CTCs and [exploiting] them as a predictive biomarker in the context of personalized anticancer treatments."

Terms of the deal were not disclosed.

Based in Paris, Rarecells was founded in 2009 to commercialize the ISET technology

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.